Intelligent Bio Solutions, Inc. - GlobeNewswire - Mon Oct 14, 7:00AM CDT NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical ...
Global Toxicology Drug Screening Market is valued at approximately USD 15.31 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.04% over the forecast period ...
The National Institutes of Health (NIH) has announced the winners of the Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge, an $8 million prize competition to ...
The NeoTRIP Phase 2 clinical trial (NCT002620280) randomized patients with triple-negative breast cancer (TNBC) to receive neoadjuvant carboplatin and nab-paclitaxel (chemotherapies to shrink tumors), ...